BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 11376873)

  • 1. Transforming growth factor-beta1 interferes with thrombopoietin-induced signal transduction in megakaryoblastic and erythroleukemic cells.
    Kalina U; Koschmieder S; Hofmann WK; Wagner S; Kauschat D; Hoelzer D; Ottmann OG
    Exp Hematol; 2001 May; 29(5):602-8. PubMed ID: 11376873
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TGF beta-induced SMAD2 phosphorylation predicts inhibition of thymidine incorporation in CD34+ cells from healthy donors, but not from patients with AML after MDS.
    Koschmieder S; Hofmann WK; Kunert J; Wagner S; Ballas K; Seipelt G; Hoelzer D; Ottmann OG; Kalina U
    Leukemia; 2001 Jun; 15(6):942-9. PubMed ID: 11417481
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thrombopoietin, but not cytokines binding to gp130 protein-coupled receptors, activates MAPKp42/44, AKT, and STAT proteins in normal human CD34+ cells, megakaryocytes, and platelets.
    Majka M; Ratajczak J; Villaire G; Kubiczek K; Marquez LA; Janowska-Wieczorek A; Ratajczak MZ
    Exp Hematol; 2002 Jul; 30(7):751-60. PubMed ID: 12135673
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Constitutive activation of the JAK2/STAT5 signal transduction pathway correlates with growth factor independence of megakaryocytic leukemic cell lines.
    Liu RY; Fan C; Garcia R; Jove R; Zuckerman KS
    Blood; 1999 Apr; 93(7):2369-79. PubMed ID: 10090948
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Establishment and characterization of the thrombopoietin-dependent megakaryocytic cell line, UT-7/TPO.
    Komatsu N; Kunitama M; Yamada M; Hagiwara T; Kato T; Miyazaki H; Eguchi M; Yamamoto M; Miura Y
    Blood; 1996 Jun; 87(11):4552-60. PubMed ID: 8639823
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thrombopoietin (TPO) induces tyrosine phosphorylation and activation of STAT5 and STAT3.
    Bacon CM; Tortolani PJ; Shimosaka A; Rees RC; Longo DL; O'Shea JJ
    FEBS Lett; 1995 Aug; 370(1-2):63-8. PubMed ID: 7544303
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of thrombopoietin, interleukin-3 and the kinase inhibitor K-252a on growth and polyploidization of the megakaryocytic cell line M-07e.
    Quentmeier H; Zaborski M; Drexler HG
    Leukemia; 1998 Oct; 12(10):1603-11. PubMed ID: 9766506
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thrombopoietin-induced conformational change in p53 lies downstream of the p44/p42 mitogen activated protein kinase cascade in the human growth factor-dependent cell line M07e.
    Ritchie A; Braun SE; He J; Broxmeyer HE
    Oncogene; 1999 Feb; 18(7):1465-77. PubMed ID: 10050883
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lnk inhibits Tpo-mpl signaling and Tpo-mediated megakaryocytopoiesis.
    Tong W; Lodish HF
    J Exp Med; 2004 Sep; 200(5):569-80. PubMed ID: 15337790
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transforming growth factor-beta1 transcriptionally activates CD34 and prevents induced differentiation of TF-1 cells in the absence of any cell-cycle effects.
    Marone M; Scambia G; Bonanno G; Rutella S; de Ritis D; Guidi F; Leone G; Pierelli L
    Leukemia; 2002 Jan; 16(1):94-105. PubMed ID: 11840268
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thrombopoietin activates a STAT5-like factor in hematopoietic cells.
    Pallard C; Gouilleux F; Bénit L; Cocault L; Souyri M; Levy D; Groner B; Gisselbrecht S; Dusanter-Fourt I
    EMBO J; 1995 Jun; 14(12):2847-56. PubMed ID: 7796811
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of the receptor MPL and proliferative effects of its ligand thrombopoietin on human leukemia cells.
    Quentmeier H; Zaborski M; Graf G; Ludwig WD; Drexler HG
    Leukemia; 1996 Feb; 10(2):297-310. PubMed ID: 8637239
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thrombopoietin-induced differentiation of a human megakaryoblastic leukemia cell line, CMK, involves transcriptional activation of p21(WAF1/Cip1) by STAT5.
    Matsumura I; Ishikawa J; Nakajima K; Oritani K; Tomiyama Y; Miyagawa J; Kato T; Miyazaki H; Matsuzawa Y; Kanakura Y
    Mol Cell Biol; 1997 May; 17(5):2933-43. PubMed ID: 9111365
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A functional role of mitogen-activated protein kinases, erk1 and erk2, in the differentiation of a human leukemia cell line, UT-7/GM: a possible key factor for cell fate determination toward erythroid and megakaryocytic lineages.
    Uchida M; Kirito K; Shimizu R; Miura Y; Ozawa K; Komatsu N
    Int J Hematol; 2001 Jan; 73(1):78-83. PubMed ID: 11372759
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Involvement of prolonged ras activation in thrombopoietin-induced megakaryocytic differentiation of a human factor-dependent hematopoietic cell line.
    Matsumura I; Nakajima K; Wakao H; Hattori S; Hashimoto K; Sugahara H; Kato T; Miyazaki H; Hirano T; Kanakura Y
    Mol Cell Biol; 1998 Jul; 18(7):4282-90. PubMed ID: 9632812
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thrombopoietin induces tyrosine phosphorylation of a common beta subunit of GM-CSF receptor and its association with Stat5 in TF-1/TPO cells.
    Ooi J; Tojo A; Asano S; Sato Y; Oka Y
    Biochem Biophys Res Commun; 1998 May; 246(1):132-6. PubMed ID: 9600081
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thrombopoietin regulates Bcl-xL gene expression through Stat5 and phosphatidylinositol 3-kinase activation pathways.
    Kirito K; Watanabe T; Sawada K; Endo H; Ozawa K; Komatsu N
    J Biol Chem; 2002 Mar; 277(10):8329-37. PubMed ID: 11756417
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thrombopoietin induces tyrosine phosphorylation and activation of mitogen-activated protein kinases in a human thrombopoietin-dependent cell line.
    Yamada M; Komatsu N; Okada K; Kato T; Miyazaki H; Miura Y
    Biochem Biophys Res Commun; 1995 Dec; 217(1):230-7. PubMed ID: 8526916
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A new feature of Mpl receptor: ligand-induced transforming activity in FRE rat fibroblasts.
    Challier C; Cocault L; Flon M; Pauchard M; Porteu F; Gisselbrecht S; Souyri M
    Oncogene; 2000 Apr; 19(16):2033-42. PubMed ID: 10803464
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation of the Jak-Stat- and MAPK-pathways by oncostatin M is not sufficient to cause growth inhibition of human glioma cells.
    Halfter H; Postert C; Friedrich M; Ringelstein EB; Stögbauer F
    Brain Res Mol Brain Res; 2000 Sep; 80(2):198-206. PubMed ID: 11038252
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.